Oncology

At Johnson & Johnson Oncology, we understand that the power to change the lives of those with cancer begins with a very considered step. Forwards. Whether it’s from a passing conversation, a new indication approval, or even just reaching one more patient. It is about that promise of absolute dedication and commitment to innovation, finding new solutions, and listening to patients and healthcare professionals, so we can extend and improve the quality of life for those living with cancer. That’s The Power of Purpose^TM.

Despite the incredible work of the oncology community, cancer remains the second leading cause of premature death in the world.[1][2] We fiercely believe cancer is a challenge we can collectively overcome, and our ultimate aim is to make cancer an interceptable, even curable, or chronic disease. We know that receiving a cancer diagnosis can be overwhelming and sparks fear. We are striving to change this, so that one day the words “you have cancer” will be less terrifying for patients to hear and less distressing for healthcare professionals to say and act upon.

Male nurse consulting with senior female patient and adult daughter in exam room

Our precise purpose

Every cancer is different, each possessing unique challenges along the way.[3] But we don’t try and solve all these challenges. We are precisely focused on mastering the areas where we can make the most meaningful difference for patients, partners, and the entire oncology community. To do this, we consistently integrate patients’ perspectives into everything we do.

Our focus areas

Our pipeline is taking science from where it is to where it has not been before, through targeted transformation.

Multiple Myeloma

We want to improve treatment efficacy for patients with this rare, incurable blood cancer.

Prostate Cancer

We have over ten years’ experience in research in prostate cancer, the most common cancer among men in South Africa.

JJIM Images/JJ_Photo_Three generations of women at home_GettyImages_1020355534_1Star 9.56.29 AM.jpg

B-cell malignancies

There are many different types of B cell malignancies.[4] We’re focused on five main types.

Lung Cancer

We’re concentrating on developing targeted therapies for patients with lung cancer, the leading cause of cancer death for men and women globally. [5]

Resources

Here4You

Here4You is a portal of information, to provide hope and support to those living with prostate cancer, as well as loved ones and family.

Learn more

Transparency

We are committed to transparency and integrity in our interactions with healthcare professionals and organizations. The following provides detailed reports on our Transfers of Value (ToV), reflecting our dedication to compliance and fostering trust within the medical community.

Campaigning for Cancer

Campaigning for Cancer is a patient advocacy organisation formed in 2008 to give a voice to South African cancer patients and those affected by cancer. The pioneer of South African cancer patient advocacy, Campaigning for Cancer continues to advocate for the promotion and protection of the rights of patients and those affected by cancer with regard to policy, healthcare costs and healthcare delivery. Campaigning for Cancer does this on an individual patient level – changing one life at a time – by providing people with the knowledge and tools to see their treatment process through; as well as on a larger scale, by noting issues highlighted by these individual cases and advocating for policy change that will affect all of society.

City of Organisation: Johannesburg, South Africa

Web address of organisation: campaign4cancer.co.za

Project description: Multiple Myeloma Patient Advisory Board to gain patient insights into their understanding of multiple myeloma.

Contract signed: 23 March 2021
Fee for service: R20 500.00

Project description: Support for the creation of blood cancer information on the C4C portal pages.

The objective of this program is to aid South African cancer patients in accessing credible and reliable information about their disease and their cancer journey. The platform will inform and aid patients and those affect by blood cancer in managing their rights and responsibilities by providing tools & point of referral across the cancer landscape to aid them at the point of symptoms, diagnosis and during treatment, palliation and survivorship.

Contract signed: 19 November 2020
Contribution made by Janssen: R100 000.00

Project description: Patient Advocacy Group Capability Building Project

Contract signed: 19 November 2020
Contribution made by Janssen: R340 000.00

Project description: CLL Awareness Campaign to facilitate the furthering of CLL awareness in South Africa

Contract signed: 19 November 2020
Contribution made by Janssen: R133 000.00

Project description: Multiple Myeloma Awareness Campaign to facilitate the furthering of Multiple Myeloma awareness in South Africa

Contract signed: 17 March 2020
Contribution made by Janssen: R149 000.00

References:

[1] World Health Organization Regional Office for Europe. Cancer data and statistics. Available at https://www.who.int/health-topics/noncommunicable-diseases#tab=tab_1 Accessed December 2020.
[2] Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356-387.
[3] Ogino S. et al. Expert Rev Mol Diagn. 2012; 12(6): 621–628. 2 TBC
[4] WebMD. What Is B-Cell Lymphoma: Available at: https://www.webmd.com/cancer/lymphoma/what-is-b-cell-lymphoma#1. Accessed June 2021.
[5] Cancer.Net. Lung Cancer - Non-Small Cell: Statistics. Available at: https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics. Accessed December 2020.

CP-497731 | January 2025

Search Results

No Results

Recently Viewed

Oncology